Acquired by @ICONplc as of July 2017
Joined May 2013
- Tweets 11,997
- Following 4,409
- Followers 1,390
- Likes 2,006
2,099 Photos and videos
Pinned Tweet
28 Mar 2019
Thank you to all our followers, @MapiGlobal will no longer be updated. Please follow us at @ICONplc ow.ly/LCZz30odUz3
26 Feb 2019
There are over 6,000 #raredisease types. Learn more from #ICONplc @ICONplc this #RareDiseaseDay ow.ly/a7gG50lYy8s
2
Wishing you happy holidays and a wonderful New Year. Best wishes from all @ICONplc ow.ly/Gy0d30n2Chw
4
4
13 Dec 2018
Overcome the challenges of #oncology #clinicaltrials with @ICONplc's strategic approach ow.ly/clDZ50iUIdj
5
26 Nov 2018
Explore the key challenges of declining #researchanddevelopment (R&D) efficiency in this @ContractPharma article featuring ICON #thoughtleadership ow.ly/LVxM30mHOGY
7 Nov 2018
Discover #bioanalyticalmethods that can be leveraged to add value in #earlyphase #clinicalstudies in @ICONplc's recent blog post ow.ly/qNiH50iXinW
1
1
6 Nov 2018
Making smarter, more timely decisions in #earlyphase #clinicaldevelopmentprogrammes can be achieved by adopting an #adaptivedesign. Discover how @ICONplc can help here ow.ly/sE1c50j3MXu
1
31 Oct 2018
Estimates show that #COPD will become the third leading cause of death by 2030, according to @WHO. Learn about @ICONplc’s #clinicaltrial solutions for the life-threatening #lungdisease here ow.ly/wKKg50jtn1u
1
1
26 Oct 2018
‘Embracing #disruption for a new era in healthcare’ is the theme for this year’s Global @FT #Pharma & #Biotech Conference (London; 5-6 Nov). Request @ICONplc's 25% registration discount code today to signup to attend ow.ly/hT8Q30mnvT0
1
25 Oct 2018
Discover how @ICONplc's experts met the first-patient-in goal for two non- #cysticfibrosis #bronchiectasis phase III #clinicalstudies ow.ly/NJPH50jtmKu
1
2
25 Oct 2018
Over the past 3 years, ICON has conducted 24 #respiratory clinical studies, which included 874 #clinicaltrial sites globally & more than 400 experienced respiratory team members. Learn more about @ICONplc's integrated approach to #pulmonary trials ow.ly/yM8q50jtkMB
1
24 Oct 2018
Approvals for #carttherapies are increasing & scaling up requires overcoming new challenges. Explore @ICONplc's potential solutions @ ow.ly/Xu3J50j3AUx
1
23 Oct 2018
Learn how to enhance #patientoutcomes in #immunooncology #clinicaltrials with thoughtful planning & more treatment options in @ICONplc's white paper ow.ly/1WeO50jtprr
3
22 Oct 2018
Discover @ICONplc's strategies for maintaining #clinicalsite relationships and enhancing #patientrecruitment in #IBD #clinicalstudies ow.ly/2T5150iUFjb
1
18 Oct 2018
Explore @ICONplc's tailored solutions to #IBD #clinicaltrial #patientenrolment challenges in our phase 2a case study ow.ly/hYmd50iUupz
2
17 Sep 2018
We are excited to be shortlisted for the @Medtech_Insight #MedTech18 In Vivo Award for Best #Medtech Partnership / Alliance in recognition of how our work with the @bostonsci RM team has set a new benchmark in partnering activity ow.ly/GUcq30lqYGE
1
1
17 Sep 2018
The blood brain barrier is a significant hurdle when it comes to bringing some, at least larger, molecules to the brain. Read this @DDNewsOnline article featuring @ICONplc insights to learn more ow.ly/CEky30lxi9G
3
14 Sep 2018
#WorldAlzheimersDay is Friday, 9/21. Discover how @ICONplc continues to support #Alzheimers and similar #CNS diseases research with this infographic ow.ly/nsy350iG5lm
3
11 Sep 2018
#Precisionmedicine has facilitated the emergence of companion diagnostics in a variety of #therapeutic areas. Discover what’s next in @ICONplc's latest blog post ow.ly/AcT730lLVQb
2
30 Aug 2018
#Blockchain: The Future for #ClinicalResearch Data Integrity? #ICONplc’s Michel Goosens thinks so. Learn why here - ow.ly/ZJTj30lp5Wx
1